516 related articles for article (PubMed ID: 31657509)
1. The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis.
Lawson EA; Olszewski PK; Weller A; Blevins JE
J Neuroendocrinol; 2020 Apr; 32(4):e12805. PubMed ID: 31657509
[TBL] [Abstract][Full Text] [Related]
2. Leptin activates oxytocin neurons of the hypothalamic paraventricular nucleus in both control and diet-induced obese rodents.
Perello M; Raingo J
PLoS One; 2013; 8(3):e59625. PubMed ID: 23527232
[TBL] [Abstract][Full Text] [Related]
3. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass.
Maejima Y; Iwasaki Y; Yamahara Y; Kodaira M; Sedbazar U; Yada T
Aging (Albany NY); 2011 Dec; 3(12):1169-77. PubMed ID: 22184277
[TBL] [Abstract][Full Text] [Related]
4. Role of oxytocin signaling in the regulation of body weight.
Blevins JE; Ho JM
Rev Endocr Metab Disord; 2013 Dec; 14(4):311-29. PubMed ID: 24065622
[TBL] [Abstract][Full Text] [Related]
5. Low sympathetic tone and obese phenotype in oxytocin-deficient mice.
Camerino C
Obesity (Silver Spring); 2009 May; 17(5):980-4. PubMed ID: 19247273
[TBL] [Abstract][Full Text] [Related]
6. Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans.
Blevins JE; Baskin DG
Physiol Behav; 2015 Dec; 152(Pt B):438-49. PubMed ID: 26013577
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Effects of Oxytocin.
McCormack SE; Blevins JE; Lawson EA
Endocr Rev; 2020 Apr; 41(2):121-45. PubMed ID: 31803919
[TBL] [Abstract][Full Text] [Related]
8. Novel Long-Acting Oxytocin Analog with Increased Efficacy in Reducing Food Intake and Body Weight.
Elfers CT; Blevins JE; Salameh TS; Lawson EA; Silva D; Kiselyov A; Roth CL
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232550
[TBL] [Abstract][Full Text] [Related]
9. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity.
Iwasaki Y; Maejima Y; Suyama S; Yoshida M; Arai T; Katsurada K; Kumari P; Nakabayashi H; Kakei M; Yada T
Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R360-9. PubMed ID: 25540101
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin enhances cognitive control of food craving in women.
Striepens N; Schröter F; Stoffel-Wagner B; Maier W; Hurlemann R; Scheele D
Hum Brain Mapp; 2016 Dec; 37(12):4276-4285. PubMed ID: 27381253
[TBL] [Abstract][Full Text] [Related]
11. Intranasal oxytocin reduces weight gain in diet-induced obese prairie voles.
Seelke AM; Rhine MA; Khun K; Shweyk AN; Scott AM; Bond JM; Graham JL; Havel PJ; Wolden-Hanson T; Bales KL; Blevins JE
Physiol Behav; 2018 Nov; 196():67-77. PubMed ID: 30144467
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin signaling in the posterior hypothalamus prevents hyperphagic obesity in mice.
Inada K; Tsujimoto K; Yoshida M; Nishimori K; Miyamichi K
Elife; 2022 Oct; 11():. PubMed ID: 36281647
[TBL] [Abstract][Full Text] [Related]
13. OXYTOCIN - AN EMERGING TREATMENT FOR OBESITY AND DYSGLYCEMIA: REVIEW OF RANDOMIZED CONTROLLED TRIALS AND COHORT STUDIES.
Barengolts E
Endocr Pract; 2016 Jul; 22(7):885-94. PubMed ID: 27018619
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin Involvement in Body Composition Unveils the True Identity of Oxytocin.
Camerino C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203705
[TBL] [Abstract][Full Text] [Related]
15. The Neuropeptide Hormone Oxytocin in Eating Disorders.
Plessow F; Eddy KT; Lawson EA
Curr Psychiatry Rep; 2018 Sep; 20(10):91. PubMed ID: 30178087
[TBL] [Abstract][Full Text] [Related]
16. Relay of peripheral oxytocin to central oxytocin neurons via vagal afferents for regulating feeding.
Iwasaki Y; Kumari P; Wang L; Hidema S; Nishimori K; Yada T
Biochem Biophys Res Commun; 2019 Nov; 519(3):553-558. PubMed ID: 31537381
[TBL] [Abstract][Full Text] [Related]
17. The New Frontier in Oxytocin Physiology: The Oxytonic Contraction.
Camerino C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708109
[TBL] [Abstract][Full Text] [Related]
18. Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas.
Maejima Y; Rita RS; Santoso P; Aoyama M; Hiraoka Y; Nishimori K; Gantulga D; Shimomura K; Yada T
Neuroendocrinology; 2015; 101(1):35-44. PubMed ID: 25573626
[TBL] [Abstract][Full Text] [Related]
19. Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats.
Roberts ZS; Wolden-Hanson T; Matsen ME; Ryu V; Vaughan CH; Graham JL; Havel PJ; Chukri DW; Schwartz MW; Morton GJ; Blevins JE
Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R357-R371. PubMed ID: 28747407
[TBL] [Abstract][Full Text] [Related]
20. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys.
Blevins JE; Graham JL; Morton GJ; Bales KL; Schwartz MW; Baskin DG; Havel PJ
Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R431-8. PubMed ID: 25540103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
